Tags: Coronavirus | us | eli lilly | coronavirus | antibodu therapy

US to Buy at Least 100K Doses of Lilly's COVID-19 Antibody Therapy

lilly corporate hq sign
(Dreamstime)

Friday, 26 February 2021 07:20 AM

Drugmaker Eli Lilly and Co said on Friday the U.S. government has agreed to buy at least 100,000 doses of its newly authorized COVID-19 dual antibody cocktail for $210 million, with doses to be delivered through March-end.

The U.S. government will have the option to purchase up to an additional 1.1 million doses through Nov. 25, the company said.

The therapy contains two antibodies, bamlanivimab and etesevimab, and had got U.S. emergency use authorization earlier this month for the treatment of mild to moderate COVID-19 in patients who are at high risk of progressing to severe disease or hospitalization.

The United States had already agreed to buy 1.45 million doses of bamlanivimab alone, Lilly said, adding that 1 million of doses have already been delivered and 450,000 additional doses will be delivered by March-end. 

© 2021 Thomson/Reuters. All rights reserved.


StreetTalk
Drugmaker Eli Lilly and Co said on Friday the U.S. government has agreed to buy at least 100,000 doses of its newly authorized dual antibody COVID-19 cocktail for $210 million, with doses to be delivered through March-end....
us, eli lilly, coronavirus, antibodu therapy
134
2021-20-26
Friday, 26 February 2021 07:20 AM
Newsmax Media, Inc.
 
Newsmax TV Live
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved